Andon Health Co Ltd
SZSE:002432
Andon Health Co Ltd
Cash & Cash Equivalents
Andon Health Co Ltd
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Andon Health Co Ltd
SZSE:002432
|
Cash & Cash Equivalents
¥2.2B
|
CAGR 3-Years
25%
|
CAGR 5-Years
42%
|
CAGR 10-Years
21%
|
|
A
|
APT Medical Inc
SSE:688617
|
Cash & Cash Equivalents
¥1.3B
|
CAGR 3-Years
120%
|
CAGR 5-Years
70%
|
CAGR 10-Years
N/A
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Cash & Cash Equivalents
¥6.6B
|
CAGR 3-Years
45%
|
CAGR 5-Years
49%
|
CAGR 10-Years
38%
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Cash & Cash Equivalents
¥18.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Cash & Cash Equivalents
¥4.8B
|
CAGR 3-Years
19%
|
CAGR 5-Years
14%
|
CAGR 10-Years
22%
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Cash & Cash Equivalents
¥9.9B
|
CAGR 3-Years
77%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Andon Health Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
2.2B
CNY
Based on the financial report for Mar 31, 2024, Andon Health Co Ltd's Cash & Cash Equivalents amounts to 2.2B CNY.
What is Andon Health Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
21%
Over the last year, the Cash & Cash Equivalents growth was -60%. The average annual Cash & Cash Equivalents growth rates for Andon Health Co Ltd have been 25% over the past three years , 42% over the past five years , and 21% over the past ten years .